This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Malignant neoplasm of base of tongue, excluding all cancers (controls excluding all cancers)
C3_BASEOFTONGUE_EXALLC
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
3 out of 7 registries used, show all original rules. |
290 |
4. Check minimum number of eventsNone |
290 |
5. Include endpointsNone |
290 |
6. Filter based on genotype QC (FinnGen only) |
290 |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE_EXALLC
Extra metadata
- First used in FinnGen datafreeze
- DF12
Similar endpoints
↥List of similar endpoints to
Malignant neoplasm of base of tongue, excluding all cancers (controls excluding all cancers)
based on the number of shared cases.
Similar with more cases:
- Malignant neoplasm of tongue, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm of oral cavity, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm of head and neck, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm, wide definition for exclusion
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 290 | 79 | 211 |
| Unadjusted period prevalence (%) | 0.08 | 0.03 | 0.09 |
| Median age at first event (years) | 62.59 | 62.58 | 62.59 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 180
- Matched controls
- 1801
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
C01
ICD-10 Finland
Malignant neoplasm of base of tongue
+∞
198.7
152
*
130
Kela drug reimbursment
Malignant tumour
+∞
171.4
136
*
8070/3-C01.9
ICD-O-3
Squamous cell carcinoma, NOS, of base of tongue, NOS
+∞
160.3
129
*
504
Kela drug reimbursment
Conditions requiring daily forced enteral nutrition
1437.3
132.6
113
*
JDB10
NOMESCO Finland
Percutaneous gastrostomy
1048.1
109.0
96
*
WF002
NOMESCO Finland
Radical radiotherapy
+∞
104.7
90
*
A03FA01
ATC
metoclopramide; systemic, rectal
42.8
87.9
115
71
UJC01
NOMESCO Finland
Scopy of lower throat
414.6
79.3
74
*
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
+∞
73.0
65
*
N02AA05
ATC
oxycodone; systemic
25.6
67.1
102
87
EJA10
NOMESCO Finland
Biopsy of tongue or floor of mouth
98.9
56.4
60
9
H02AB02
ATC
dexamethasone; systemic
134.1
54.5
56
6
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
11.9
48.8
116
237
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
+∞
48.1
44
*
C77.0
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Lymph nodes of head, face and neck
+∞
47.0
43
*
A04AA01
ATC
ondansetron; systemic, rectal
108.0
45.5
48
6
A04AA02
ATC
granisetron; systemic, transdermal
537.7
44.2
42
*
YA1BD
NOMESCO Finland
Extensive CT examination of head and neck for dose design of radiotherapy
+∞
41.2
38
*
WF003
NOMESCO Finland
Adjuvant radiotherapy
+∞
40.1
37
*
R4190
NOMESCO Finland
Nutritional therapy
43.0
39.1
48
15
R22.1
ICD-10 Finland
Localized swelling, mass and lump, neck
29.9
38.5
52
24
YA1VG
NOMESCO Finland
MRI examination of head and neck with high intesity magnet for dose design of radiotherapy
+∞
37.9
35
*
EP1AE
NOMESCO Finland
Neck ultrasound examination
27.6
37.6
52
26
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
55.8
37.0
43
10
XX3DW
NOMESCO Finland
Time consuming IT work
24.5
36.9
53
30
GDA98
NOMESCO Finland
Other bronchoscopic incision, excision of lesion or repair of lung
436.9
36.3
35
*
ZX090
NOMESCO Finland
Other technic of radiotherapy
+∞
34.5
32
*
EJB20
NOMESCO Finland
Excision of lesion of base of tongue
+∞
34.5
32
*
EN1BD
NOMESCO Finland
Very extensive CT examination of mouth and soft tissues of neck
92.4
34.3
37
5
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
38.4
29.5
37
12
WX408
NOMESCO Finland
General anesthesy, balanced
7.0
29.5
91
228
PJD81
NOMESCO Finland
Excision of lymph nodes from upper part of neck
+∞
28.9
27
*
EP1CG
NOMESCO Finland
Extensive MRI examination of soft tissue of neck with high intesity magnet
119.2
28.6
30
*
GBB00
NOMESCO Finland
Tracheostomy
57.3
28.6
33
7
ZX095
NOMESCO Finland
Combined chemoradiotherapy
+∞
27.8
26
*
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
5.9
27.6
117
429
A04AD12
ATC
aprepitant; systemic
+∞
26.7
25
*
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
+∞
26.7
25
*
A07AA02
ATC
nystatin; oral
15.3
24.9
42
35
YA1CD
NOMESCO Finland
Very extensive CT examination of head and neck for dose design of radiotherapy
+∞
24.5
23
*
PJD71
NOMESCO Finland
Extended sparing excision of cervical lymph nodes
+∞
24.5
23
*
YA1AD
NOMESCO Finland
CT examination of head and neck for dose design of radiotherapy
+∞
24.5
23
*
WZC30
NOMESCO Finland
Teaching
8.6
24.5
58
94
ENA10
NOMESCO Finland
Biopsy of pharynx
275.1
24.3
24
*
ZX070
NOMESCO Finland
Intensity modified radiotherapy
+∞
23.4
22
*
C02.11
ICD-10 Finland
Malignant neoplasm of border of tongue
+∞
23.4
22
*
UDQ12
NOMESCO Finland
Flexible laryngoscopy
11.4
23.1
45
51
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
10.9
23.0
46
55
EBA15
NOMESCO Finland
Extraction of large number of teeth
13.6
22.6
40
37
SAA03
NOMESCO Finland
Extended examination of mouth
4.9
22.4
108
421
EP1DG
NOMESCO Finland
Very extensive examination of soft tissue of neck with high intesity magnet
131.0
22.1
23
*
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
10.4
21.6
44
54
K08.1
ICD-10 Finland
Loss of teeth due to accident, extraction or local periodontal disease
8.3
21.4
51
82
JCW98
NOMESCO Finland
Other transluminal endoscopic procedure on oesophagus
+∞
21.3
20
*
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
236.2
21.0
21
*
JN4KR
NOMESCO Finland
Whole body very extensive metabolic PET with CT
+∞
20.2
19
*
D10.10
ICD-10 Finland
Benign tumor at the base of the tongue
+∞
18.0
17
*
WF049
NOMESCO Finland
Radiotherapy of metastasis
+∞
18.0
17
*
WX402
NOMESCO Finland
General anaesthesia
5.7
17.5
56
132
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
12.2
17.0
31
30
A04AA55
ATC
palonosetron, combinations; systemic
+∞
16.9
16
*
D37.08
ICD-10 Finland
Tumor of uncertain or unknown nature in other part of lip, oral cavity and pharynx
+∞
16.9
16
*
QA1S1
NOMESCO Finland
Photography of skin or subcutaneous tissue in head
99.5
16.9
18
*
WZC10
NOMESCO Finland
Extensive specialist consultion with written report
17.6
16.8
26
17
EMB10
NOMESCO Finland
Tonsillectomy
13.6
16.8
29
25
K04.5
ICD-10 Finland
Chronic apical periodontitis
4.2
16.5
78
275
A06AD11
ATC
lactulose; oral
5.4
16.0
53
129
OAB73
NOMESCO Finland
Prevention and treatment of malnutrition
+∞
15.9
15
*
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
+∞
15.9
15
*
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
174.5
15.7
16
*
UDH02
NOMESCO Finland
Rhinopharyngoscopy
7.9
15.3
36
55
PJD51
NOMESCO Finland
Block dissection of cervical lymph nodes
+∞
14.8
14
*
C02.9
ICD-10 Finland
Malignant neoplasm: Tongue, unspecified
+∞
14.8
14
*
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
14.8
14
*
Z51.5
ICD-10 Finland
Palliative care
19.6
14.2
21
12
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
13.7
13
*
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
+∞
13.7
13
*
WF004
NOMESCO Finland
Palliative radiotherapy
+∞
13.7
13
*
C61
ICD-10 Finland
Malignant neoplasm of prostate
150.9
13.6
14
*
EBA10
NOMESCO Finland
Surgical removal of tooth
6.8
13.4
35
62
R13
ICD-10 Finland
Dysphagia
7.4
13.2
32
51
WX002
NOMESCO Finland
Sedation and analgesia
4.1
13.0
58
187
C02.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of tongue
+∞
12.6
12
*
C02.4
ICD-10 Finland
Malignant neoplasm: Lingual tonsil
+∞
12.6
12
*
EN1AD
NOMESCO Finland
CT examination of mouth and soft tissues of neck
40.6
12.4
15
*
ZXC96
NOMESCO Finland
Robot assisted procedure
50.2
12.1
14
*
SBB00
NOMESCO Finland
Fotograf of mouth and teeth
13.1
11.7
20
17
JN4JR
NOMESCO Finland
Whole body extensive metabolic PET with CT
+∞
11.6
11
*
WX110
NOMESCO Finland
Local anesthesy
3.1
11.3
131
829
WW500
NOMESCO Finland
Blood transfusion
13.1
11.1
19
16
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
9.5
10.9
22
26
PJ3AT
NOMESCO Finland
Cytology of lymphnode with ultrasound guidance
116.5
10.5
11
*
WZC05
NOMESCO Finland
Specialty-specific consultation based on referral by dentist or doctor
8.8
10.5
22
28
SBB10
NOMESCO Finland
Teeth copy
8.8
10.5
22
28
SCA02
NOMESCO Finland
Analysis and advice of nutrition with regard to dentistry
5.6
10.2
30
62
WX404
NOMESCO Finland
Intravenous generell anesthesy
3.9
10.0
44
138
K05.31
ICD-10 Finland
Periodontitis pronounced
4.3
9.9
38
105
UGC12
NOMESCO Finland
Flexible bronchoscopy
5.3
9.8
30
65
K05.30
ICD-10 Finland
Periodontitis complex
4.1
9.8
40
117
D10.19
ICD-10 Finland
Benign tumor of the tongue UNS
58.2
9.8
11
*
TJD20
NOMESCO Finland
Change of gastrostomy tube
+∞
9.5
9
*
8085/3-C01.9
ICD-O-3
Squamous cell carcinoma, HPV positive of base of tongue, NOS
+∞
9.5
9
*
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
+∞
9.5
9
*
L03AA13
ATC
pegfilgrastim; parenteral
+∞
9.5
9
*
TJD00
NOMESCO Finland
Insertion of nasogastric or naso-gastroduodenal tube
19.9
9.1
13
7
R07.0
ICD-10 Finland
Pain in throat
7.9
9.0
20
28
R59.0
ICD-10 Finland
Localized enlarged lymph nodes
15.0
8.8
14
10
JN6AD
NOMESCO Finland
CT of torso and neck
94.3
8.5
9
*
WX707
NOMESCO Finland
Fiberoscopic intubation
+∞
8.4
8
*
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
+∞
8.4
8
*
116
Kela drug reimbursment
Prostate cancer
+∞
8.4
8
*
K10.26
ICD-10 Finland
Periostitis of jaw (acute)(chronic)(suppurative)
+∞
8.4
8
*
K11.70
ICD-10 Finland
Hypoptyalism
+∞
8.4
8
*
ZZQ00
NOMESCO Finland
Free microvascular graft of skin
+∞
8.4
8
*
EBB15
NOMESCO Finland
Insertion of dental implant abutment
+∞
8.4
8
*
C02.10
ICD-10 Finland
Malignant neoplasm of tip of tongue
+∞
8.4
8
*
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.8
8.4
63
288
ED1AA
NOMESCO Finland
Mandipular X-ray examination
35.1
8.2
10
*
SXB00
NOMESCO Finland
Removeal of sutres from oral mucosa
5.5
7.9
23
47
SCA04
NOMESCO Finland
Guidance on care of mouth and oral mucosa
47.1
7.8
9
*
EB1BI
NOMESCO Finland
Cone beam imaging of teeth and jaws (1–2 quarters)
47.1
7.8
9
*
JN4BD
NOMESCO Finland
Extensive body CT
5.5
7.7
22
44
TPX10
NOMESCO Finland
Implantation of vascular injection port
19.4
7.7
11
6
GD5BD
NOMESCO Finland
Thorax and upper abdomen combined extensive CT examination of
14.2
7.5
12
9
UDQ22
NOMESCO Finland
Microlaryngoscopy
14.2
7.5
12
9
C83.31
ICD-10 Finland
Diffuse lymphoma with large B cells
+∞
7.3
7
*
QA7S1
NOMESCO Finland
Photography of skin or subcutaneous tissue in jaw or lips
+∞
7.3
7
*
9680/3-C01.9
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of base of tongue, NOS
+∞
7.3
7
*
D10.5
ICD-10 Finland
Benign neoplasm: Other parts of oropharynx
+∞
7.3
7
*
SAA04
NOMESCO Finland
Special inverstigation of mouth
7.1
7.3
17
26
JN4AD
NOMESCO Finland
Body CT examination
8.5
7.3
15
19
L03AA02
ATC
filgrastim; parenteral
31.4
7.2
9
*
ECB20
NOMESCO Finland
Oral alveoplasty
31.4
7.2
9
*
A02BC05
ATC
esomeprazole; systemic
2.4
7.2
82
463
R4110
NOMESCO Finland
Physiotherapy
2.7
7.1
56
258
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.3
6.7
85
501
WX105
NOMESCO Finland
Surface analgesia on skin or mucosa
3.8
6.6
28
84
EBA00
NOMESCO Finland
Extraction of tooth
2.4
6.6
67
354
J02AC01
ATC
fluconazole; systemic
2.5
6.5
63
323
UJC02
NOMESCO Finland
Rigid oesophagoscopy
15.0
6.5
10
7
JN4CD
NOMESCO Finland
Very extensive body CT
15.0
6.5
10
7
WD305
NOMESCO Finland
Simple therapy of methastized malignancy with biomodifiers
72.3
6.5
7
*
GD6BD
NOMESCO Finland
Extensive CT of chest and neck
72.3
6.5
7
*
K02.1
ICD-10 Finland
Caries of dentine
2.2
6.4
104
684
R21
ICPC
Throat symptom/complaint
3.1
6.3
35
129
K10.21
ICD-10 Finland
Osteoradionecrosis of jaw (acute)(chronic)(suppurative)
+∞
6.3
6
*
UJC20
NOMESCO Finland
Extensive endoscopy to identify diagnosed or suspected primary malignant neoplasm of head or neck
+∞
6.3
6
*
YX9BD
NOMESCO Finland
Other extensive CT eamination for dose design of radiotherapy
+∞
6.3
6
*
ZXF99
NOMESCO Finland
Other r3eason to interrupt procedure
+∞
6.3
6
*
SXC03
NOMESCO Finland
Other oral or dental procedure
27.7
6.3
8
*
T05
ICPC
Feeding problem of adult
27.7
6.3
8
*
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.9
6.2
41
167
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(4035726)
142
74
36.64
195.34
1.6
1.3
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
66
24
35.31
100.13
1.3
1.3
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
194
655
6.93
58.37
3.2
1.6
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
160
646
4.29
33.62
6.8
2.1
mmol/l
2.4
2.4
1.56
149
538
(3013650) Neutrophils [#/volume] in Blood by Automated count
223
1221
4.58
28.82
13.0
6.1
e9/l
4.0
4.3
1.03
203
1063
(3002256) Pathology report gross observation
69
168
5.08
27.55
1.4
1.1
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
144
614
3.67
26.43
3.0
2.1
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
180
907
3.60
24.99
4.4
3.6
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
120
474
3.61
24.44
2.8
2.1
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
198
1107
3.49
22.29
9.6
4.1
umol/l
10.7
12.3
1.10
192
1040
(40758558) Short blood count panel - Blood
113
498
3.08
18.31
10.7
4.6
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
125
584
3.00
18.23
4.8
3.7
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
170
945
2.93
17.87
6.5
3.6
g/l
34.8
35.6
1.05
159
883
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
168
967
2.75
15.89
6.9
5.0
mmol/l
1.2
1.2
0.23
159
857
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
174
1060
2.60
14.05
7.8
5.5
mmol/l
1.2
1.2
0.06
148
903
(42870588) Differential panel, method unspecified - Blood
132
707
2.59
13.95
6.2
5.4
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
107
520
2.68
13.77
1.5
1.3
—
—
—
0
0
(3018418) pH of Serum or Plasma
119
612
2.60
13.62
4.1
3.3
ph
7.4
7.4
0.38
24
100
(3032080) INR in Blood by Coagulation assay
159
943
2.52
13.37
6.5
9.2
inr
1.1
1.3
5.08
40
253
(3022096) Basophils/100 leukocytes in Blood
164
989
2.51
13.27
5.9
5.4
%
0.6
0.7
0.65
154
921
(3035637) Corticotropin [Mass/volume] in Plasma
15
15
10.49
13.24
1.5
1.2
—
—
—
0
0
(3006504) Eosinophils/100 leukocytes in Blood
167
1018
2.51
13.17
6.4
5.5
%
2.5
3.1
3.51
156
945
(3019069) Monocytes/100 leukocytes in Blood
165
1023
2.42
12.21
7.0
5.7
%
9.2
8.9
0.66
156
955
(3006315) Basophils [#/volume] in Blood
173
1099
2.42
12.07
6.0
5.3
e9/l
0.0
0.0
1.84
145
953
(3001604) Monocytes [#/volume] in Blood
172
1090
2.42
12.06
6.0
5.3
e9/l
0.6
0.6
0.10
145
937
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
40
120
3.71
11.72
9.6
6.8
mmol/l
25.2
24.9
0.27
35
110
(3013115) Eosinophils [#/volume] in Blood
175
1127
2.39
11.70
6.2
5.4
e9/l
0.2
0.2
3.11
150
993
(3007853) Bacteria identified in Skin by Aerobe culture
67
276
2.86
11.66
1.9
1.6
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
165
1046
2.34
11.30
6.5
5.6
%
22.2
27.2
6.44
156
969
(3026389) Candida sp identified in Specimen by Organism specific culture
16
22
7.64
11.10
1.6
1.2
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
172
1116
2.33
11.07
6.0
5.3
e9/l
1.8
1.9
0.06
146
982
(3018010) Neutrophils/100 leukocytes in Blood
162
1039
2.27
10.53
6.2
5.4
%
61.6
57.4
3.89
152
969
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
72
324
2.63
10.48
2.0
1.7
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
82
399
2.47
10.10
6.4
2.0
mmol/l
2.5
2.4
4.45
73
340
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
52
204
2.89
9.81
3.7
2.7
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
57
235
2.77
9.80
2.9
2.4
umol/l
9.8
8.3
0.15
47
209
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
14
8
18.31
9.49
1.1
1.1
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
37
123
3.30
9.23
1.8
1.7
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
14
9
16.26
9.12
4.1
2.4
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
13
7
19.36
9.01
1.1
1.0
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
34
110
3.37
8.85
1.2
1.2
iu/ml
182.2
122.1
—
10
44
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
45
178
2.81
8.31
3.4
2.0
ml/min/173m2
73.0
63.8
0.47
12
71
(3000494) Fungus identified in Specimen by Culture
60
282
2.42
7.81
1.7
1.4
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
52
229
2.55
7.77
2.1
1.8
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
52
230
2.54
7.70
2.1
1.7
—
—
—
0
0
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
51
226
2.52
7.51
5.9
2.5
u/l
227.7
233.9
0.16
51
209
(3003396) Base excess in Arterial blood by calculation
56
264
2.39
7.21
9.2
6.2
mmol/l
1.6
1.4
0.14
48
205
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
56
266
2.37
7.08
9.3
6.2
kpa
5.4
5.2
1.41
51
257
(3021589) Normoblasts [#/volume] in Blood
142
964
1.93
6.94
13.5
8.0
e9/l
0.0
0.0
0.50
110
785
(3000991) Gas panel - Venous blood
44
193
2.51
6.60
9.2
6.3
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
41
180
2.49
6.13
4.0
2.1
u/l
65.3
42.4
0.47
35
145
(3014111) Lactate [Moles/volume] in Serum or Plasma
45
210
2.35
5.89
9.2
5.0
mmol/l
1.1
1.4
2.42
40
204
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
207
1646
1.90
5.69
5.3
3.4
pmol/l
14.3
14.9
3.34
202
1486
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
51
260
2.17
5.41
1.2
1.3
—
—
—
0
0
(3016502) Oxygen saturation in Arterial blood
48
239
2.21
5.39
10.4
6.4
%
95.8
95.2
0.15
48
232
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
260
2267
2.42
5.21
26.1
12.4
mg/l
26.7
23.3
1.16
239
1747
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
62
346
2.01
5.17
2.2
2.8
e6/l
1.1
1.6
0.37
37
186
(3002173) Hemoglobin [Mass/volume] in Arterial blood
43
219
2.13
4.56
11.1
6.8
g/l
116.0
123.8
1.69
43
214
(3042936) Bacteria identified in Isolate by Culture
59
339
1.93
4.50
2.2
2.0
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
89
588
1.74
4.31
2.4
2.9
e6/l
0.3
0.5
0.68
69
430
(3002582) Erythrocytes [#/volume] in Urine
96
649
1.72
4.28
2.5
3.0
e6/l
22.4
165.0
0.80
75
498
(3014576) Chloride [Moles/volume] in Serum or Plasma
53
299
1.95
4.25
7.1
5.2
mmol/l
105.0
104.0
1.00
53
290
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
11
28
4.04
4.01
1.2
1.0
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
11
28
4.04
4.01
1.5
2.0
e9/l
4.2
5.0
0.38
11
28
(36304419) Bacteria [Presence] in Urine
83
550
1.71
3.93
2.4
2.8
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
17
60
2.95
3.86
2.8
4.2
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
11
29
3.90
3.84
1.7
2.7
%
66.9
59.7
0.87
11
29
(3018095) Leukocytes [#/volume] in Urine
105
745
1.64
3.83
2.9
3.4
e6/l
247.1
124.0
0.26
79
531
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
29
136
2.26
3.76
1.5
1.4
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
60
370
1.78
3.63
2.0
2.6
e6/l
0.8
1.0
0.35
35
208
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
237
2073
1.78
3.58
5.9
4.2
mu/l
3.3
2.6
0.53
227
1871
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
8
13
6.29
3.52
1.9
1.4
g/l
1.0
1.1
—
8
13
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
71
467
1.69
3.42
4.7
3.8
ng/l
131.1
351.6
0.93
60
379
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
247
2204
1.81
3.26
24.5
11.2
ml/min/173m2
82.4
78.6
2.52
222
1774
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
12
38
3.25
3.25
1.5
1.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
12
38
3.25
3.25
1.5
1.3
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
23
108
2.23
2.99
8.0
8.8
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
13
46
2.91
2.96
1.2
1.3
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
26
130
2.10
2.91
1.6
1.5
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
13
48
2.79
2.75
1.8
1.7
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
7
14
5.09
2.74
1.3
1.3
—
—
—
0
0
(40768441) Liver Pathology biopsy report
6
10
6.10
2.71
1.2
1.3
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
62
877
0.63
2.70
3.7
4.0
mg/mmol
7.3
8.6
0.14
34
574
(40768800) Prostate Pathology biopsy report
8
19
4.30
2.69
1.0
1.2
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
57
819
0.62
2.65
2.6
3.3
mg/l
81.0
136.2
0.29
35
543
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
7
15
4.75
2.61
2.1
1.9
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
59
836
0.63
2.56
3.4
3.5
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
20
383
0.49
2.56
1.2
1.3
iu/ml
10.5
40.2
—
7
120
(3026782) Osmolality of Urine
60
408
1.59
2.50
2.3
2.6
mosm/kgh2o
540.9
572.4
0.45
49
333
(3051611) Lipemic interference index of Serum or Plasma
8
21
3.89
2.48
2.9
4.5
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
15
64
2.42
2.43
2.5
2.5
u/ml
0.2
0.3
—
8
35
(3051651) Icteric interference index of Serum or Plasma
6
12
5.08
2.41
3.3
5.0
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
6
12
5.08
2.41
1.3
1.4
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
219
2393
0.65
2.39
4.0
4.8
mmol/l
4.7
4.5
1.11
203
2219
(3009508) Creatinine [Moles/volume] in Urine
61
845
0.65
2.36
2.9
3.1
mmol/l
9.1
8.4
0.36
49
708
(3019150) Specific gravity of Urine by Refractometry
30
490
0.57
2.29
3.8
3.7
kg/l
1.0
1.0
—
6
75
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
24
418
0.54
2.29
1.2
1.2
u/ml
0.8
1.7
—
7
116
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
6
13
4.69
2.28
1.2
1.3
ug/l
13.1
17.0
—
6
13
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
0
61
0.00
2.26
0.0
1.4
—
0.9
—
0
51
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
207
2281
0.68
2.26
5.1
6.5
mmol/mol
39.2
40.7
1.77
186
2121
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
12
265
0.43
2.26
1.5
1.5
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
146
1215
1.41
2.17
2.4
2.5
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
6
14
4.35
2.16
1.5
1.3
—
—
—
0
0
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
5
10
5.07
2.08
2.0
1.3
nmol/l
1.0
4.7
—
5
10
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
5
10
5.07
2.08
2.6
1.7
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
219
2377
0.68
2.04
3.8
4.8
mmol/l
1.4
1.4
0.82
201
2193
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
8
26
3.13
2.03
2.0
1.5
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
178
1547
1.39
1.98
3.5
3.2
u/l
65.6
52.6
1.20
164
1444
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
7
21
3.39
1.97
2.3
1.4
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
5
11
4.60
1.95
1.8
1.4
—
—
—
0
0
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
5
11
4.60
1.95
1.8
1.4
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
6
16
3.81
1.94
1.0
1.2
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
99
783
1.40
1.93
2.6
2.9
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
10
40
2.55
1.85
1.8
1.4
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
92
724
1.40
1.84
3.5
2.3
u/l
49.7
58.9
1.76
87
671
(3036489) Thrombin time
14
67
2.14
1.79
1.4
2.1
s
22.0
20.9
1.34
14
60
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
43
293
1.55
1.78
1.5
1.9
%
2.3
1.6
1.08
33
247
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
21
353
0.56
1.78
1.1
1.3
u/ml
1.4
15.0
—
8
143
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
15
75
2.05
1.73
1.9
1.4
—
—
—
0
0
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
5
13
3.89
1.72
1.8
1.2
u/l
16.9
29.1
—
5
8
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
228
2439
0.70
1.69
4.3
5.4
mmol/l
2.8
2.7
0.83
206
2252
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
213
2302
0.72
1.65
3.6
4.3
mmol/l
1.4
1.3
0.32
195
2109
(3002179) Metamyelocytes/100 leukocytes in Blood
24
144
1.73
1.63
4.3
4.5
%
0.8
0.2
—
8
28
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
5
14
3.61
1.62
1.0
1.1
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
5
14
3.61
1.62
1.6
1.9
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
44
311
1.49
1.55
1.2
1.2
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
25
387
0.61
1.55
1.7
1.2
g/l
1.9
2.9
2.10
13
233
(3044889) 12 lead EKG panel
189
1693
1.33
1.53
3.9
3.9
—
—
—
0
0
(3015736) pH of Urine
65
828
0.72
1.50
2.3
3.2
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
93
755
1.34
1.50
2.4
2.2
u/l
395.0
198.8
0.46
87
705
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
9
38
2.41
1.47
1.9
1.4
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
15
81
1.90
1.43
2.1
1.5
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
51
667
0.71
1.37
2.9
2.4
umol/l
335.4
9425.7
3.45
46
584
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
5
17
2.97
1.36
1.0
1.2
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
5
17
2.97
1.36
2.0
2.4
—
—
—
0
0
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
0
37
0.00
1.35
0.0
1.1
—
14.9
—
0
7
(3009261) Glucose [Presence] in Urine by Test strip
90
1078
0.76
1.35
3.0
3.4
estimate
0.0
0.0
0.00
21
163
(3013707) Erythrocyte sedimentation rate by Westergren method
188
1699
1.30
1.34
3.5
4.0
mm/h
14.0
11.8
1.17
174
1554
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
9
175
0.50
1.34
1.6
2.5
—
13.0
—
0
7
(3027945) Reticulocytes/100 erythrocytes in Blood
38
272
1.46
1.28
1.8
2.1
%
1.9
1.7
0.70
31
249
(3000850) Epithelial cells [#/volume] in Urine
56
431
1.37
1.26
2.0
2.2
e6/l
8.6
4.1
0.62
45
367
(40761535) Cells panel - Urine sediment
10
186
0.52
1.22
2.9
2.8
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
13
71
1.87
1.21
2.1
3.9
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
22
330
0.64
1.21
4.2
5.0
%
35.8
31.1
0.86
16
219
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
8
153
0.51
1.18
1.1
1.3
—
32.3
—
0
9
(3035350) Ketones [Presence] in Urine by Test strip
89
1052
0.78
1.17
2.8
3.4
estimate
0.0
0.0
0.00
22
174
(3008757) Leukocyte morphology finding [Identifier] in Blood
5
20
2.53
1.15
9.2
2.6
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
5
112
0.44
1.15
1.2
1.8
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
60
474
1.34
1.15
1.5
1.8
mg/l
1.8
1.1
1.14
45
373
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
52
659
0.74
1.14
1.5
1.7
mmol/l
1.4
1.4
0.09
44
548
(3019060) Gas panel - Arterial blood
23
153
1.55
1.10
5.6
5.0
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
19
121
1.61
1.08
1.2
1.5
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
10
52
1.96
1.07
1.3
1.3
ug/g
260.8
295.2
—
5
29
(3020564) Creatinine [Moles/volume] in Serum or Plasma
261
2500
1.44
1.06
29.2
14.6
umol/l
78.2
82.6
2.15
261
2500
(3042111) Morphology [Interpretation] in Bone marrow Narrative
7
33
2.15
1.06
1.1
2.0
—
—
—
0
0
(3019230) Fractional oxyhemoglobin in Venous blood
9
47
1.94
1.03
1.0
2.0
%
62.8
65.6
—
9
47
(3005322) IgE [Units/volume] in Serum or Plasma
7
132
0.52
1.01
1.0
1.3
u/ml
309.6
301.2
—
7
121
(3023183) Ammonium ion [Moles/volume] in Plasma
11
61
1.83
1.00
1.9
2.8
umol/l
33.0
35.0
—
6
55
(3024891) Influenza virus A+B Ag [Presence] in Specimen
9
49
1.86
0.99
1.4
1.1
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
24
166
1.49
0.98
4.8
4.3
%
1.2
0.7
—
10
41
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
65
532
1.29
0.97
2.2
2.0
mg/l
3.0
3.0
0.06
53
451
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
64
772
0.78
0.97
2.4
3.0
ng/l
1924.4
1395.0
0.19
56
646
(3021440) Promyelocytes/100 leukocytes in Blood
23
158
1.49
0.97
5.0
4.4
%
0.1
0.1
—
10
36
(36660697) Celiac disease serology panel - Serum
8
145
0.54
0.96
1.4
1.2
—
—
—
0
0
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
6
27
2.25
0.94
4.7
1.8
u/ml
2.6
139.9
—
6
27
(3021601) Nitrite [Presence] in Urine by Test strip
92
1056
0.81
0.89
4.1
4.7
estimate
0.0
0.0
0.00
23
173
(3019225) pH of Specimen
29
214
1.39
0.86
3.3
3.2
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
8
44
1.84
0.86
1.3
1.8
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
66
551
1.26
0.85
2.5
2.9
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
98
856
1.22
0.83
2.0
2.2
nmol/l
73.4
75.4
0.26
85
748
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
121
1343
0.83
0.82
3.7
3.7
ug/l
2.2
1.9
0.66
107
1199
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
19
131
1.48
0.80
1.5
1.4
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
95
1069
0.83
0.73
3.3
3.5
%
23.2
23.3
0.02
38
472
(3024928) Oxygen saturation in Venous blood
9
57
1.60
0.72
1.1
3.1
—
—
—
0
0
(3027315) Oxygen [Partial pressure] in Blood
7
40
1.77
0.71
8.0
2.4
kpa
9.3
8.3
—
7
40
(3013290) Carbon dioxide [Partial pressure] in Blood
7
40
1.77
0.71
8.0
2.4
kpa
4.9
5.0
—
7
40
(40760892) CBC W Ordered Manual Differential panel - Blood
55
459
1.24
0.71
3.1
4.2
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
5
26
1.94
0.71
1.2
1.0
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
14
202
0.68
0.68
1.2
1.5
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
5
91
0.54
0.68
4.6
1.2
—
—
—
0
0
(4034850)
5
91
0.54
0.68
2.6
13.6
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
46
553
0.80
0.68
3.1
3.6
estimate
0.0
0.0
0.50
19
168
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
19
137
1.41
0.66
1.1
1.3
—
—
—
0
0
(21494434) Karyotype in Bone marrow
5
28
1.80
0.66
1.0
1.1
—
—
—
0
0
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
5
28
1.80
0.66
1.4
1.4
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
49
583
0.81
0.66
2.6
3.1
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
20
147
1.39
0.63
5.5
4.6
%
0.1
0.0
—
8
29
(40761511) CBC panel - Blood by Automated count
251
2428
1.25
0.61
21.2
11.7
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
24
308
0.76
0.60
6.0
7.1
—
—
—
0
0
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
0
22
0.00
0.59
0.0
1.3
—
0.4
—
0
16
(3048929) Epstein Barr virus Ab [Presence] in Serum
8
53
1.52
0.59
1.1
1.2
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
26
203
1.31
0.58
1.2
1.5
—
—
—
0
0
(1616796) Gas panel - Central venous blood
6
35
1.73
0.58
7.2
2.4
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
6
36
1.68
0.57
1.0
1.3
—
109.8
—
0
6
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
8
124
0.64
0.56
1.1
1.9
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
6
37
1.63
0.56
4.0
2.3
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
10
147
0.67
0.55
2.7
1.2
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
79
883
0.86
0.54
2.7
3.1
—
—
—
0
0
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
7
106
0.65
0.49
4.1
4.1
mmol/l
27.2
25.2
—
7
97
(3037522) Nuclear Ab [Titer] in Serum
24
298
0.79
0.48
1.3
1.3
titre
528.0
526.2
—
5
78
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
24
191
1.28
0.48
2.2
1.9
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
7
48
1.47
0.47
1.3
1.1
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
5
85
0.58
0.46
1.0
1.6
—
—
—
0
0
(40768443) Skin Pathology biopsy report
12
86
1.41
0.45
1.0
1.2
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
10
69
1.47
0.45
1.2
1.8
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
5
31
1.62
0.43
1.0
1.9
pg
29.4
34.1
—
5
31
(3004716) Salmonella sp identified in Stool by Organism specific culture
6
92
0.64
0.43
2.5
1.3
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
43
494
0.85
0.42
1.4
1.7
pmol/l
439.5
9709157.0
0.50
37
412
(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
0
15
0.00
0.41
0.0
1.1
—
1.0
—
0
9
(4027681)
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
0
16
0.00
0.41
0.0
1.4
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
0
16
0.00
0.41
0.0
1.0
—
—
—
0
0
(3036603) Volume of Urine
0
17
0.00
0.41
0.0
1.5
—
1769.2
—
0
6
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
0
19
0.00
0.39
0.0
1.7
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
43
490
0.86
0.38
2.9
3.4
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
5
36
1.40
0.38
1.0
1.2
—
—
—
0
0
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
8
113
0.70
0.38
1.5
1.8
nmol/l
38.9
40.9
—
8
106
(3023419) Bacteria identified in Sputum by Culture
5
37
1.36
0.37
2.6
3.0
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
5
37
1.36
0.37
2.2
1.3
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
9
70
1.29
0.37
1.3
1.5
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
63
569
1.14
0.36
1.5
1.5
nmol/l
19.3
20.7
0.26
51
473
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
5
76
0.65
0.36
4.6
1.2
g/l
0.1
0.3
—
5
67
(46235355) HIV 1 and 2 tests - Meaningful Use set
30
255
1.20
0.36
1.2
1.6
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
9
123
0.72
0.36
1.9
3.9
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
228
2340
0.88
0.36
4.0
4.8
mmol/l
6.0
6.1
0.80
215
2129
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
6
42
1.44
0.35
1.3
1.1
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
24
200
1.22
0.35
1.2
1.4
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
6
44
1.37
0.34
2.0
1.7
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
6
88
0.68
0.33
1.0
1.0
—
—
—
0
0
(3013512) EKG study
80
739
1.11
0.32
4.5
4.0
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
24
202
1.21
0.32
2.0
2.3
e9/l
73.5
69.1
0.20
18
163
(3039443) Prostate specific Ag panel - Serum or Plasma
11
84
1.32
0.30
1.5
1.6
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
7
55
1.28
0.30
1.3
1.3
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
10
129
0.77
0.28
1.2
2.3
—
—
—
0
0
(4094501)
5
73
0.68
0.26
1.0
1.1
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
19
160
1.20
0.26
3.4
3.0
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
18
152
1.20
0.24
4.0
2.8
e9/l
3.7
3.9
0.08
13
112
(3012544) pH of Venous blood
27
238
1.15
0.23
2.1
3.6
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
5
39
1.29
0.23
1.0
1.3
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
5
39
1.29
0.23
1.0
1.0
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
5
40
1.25
0.22
1.0
1.1
—
—
—
0
0
(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum
0
11
0.00
0.21
0.0
2.5
—
17.3
—
0
11
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(3034274) Bile acid [Moles/volume] in Serum --fasting
0
11
0.00
0.21
0.0
1.1
—
3.7
—
0
6
(3016244) Insulin [Units/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
3.3
—
25.0
—
0
10
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
(3022493) Free Hemoglobin [Mass/volume] in Plasma
0
10
0.00
0.21
0.0
3.2
—
79.8
—
0
10
(44813793)
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
9.9
—
985.7
—
0
10
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
12.3
—
1773.4
—
0
10
(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
1.3
—
183.4
—
0
10
(1002224) Polysomnography panel
8
103
0.77
0.21
1.1
1.1
—
—
—
0
0
(3003129) Base excess in Capillary blood by calculation
0
12
0.00
0.21
0.0
1.2
—
2.1
—
0
12
(3029075) Extractable nuclear Ab panel - Serum
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification
0
13
0.00
0.21
0.0
10.3
—
64.2
—
0
6
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
0
13
0.00
0.21
0.0
1.4
—
—
—
0
0
(3022313) Gas panel - Capillary blood
10
123
0.81
0.20
3.9
3.7
—
—
—
0
0
(3024263) Appearance of Synovial fluid
0
14
0.00
0.20
0.0
1.3
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
0
14
0.00
0.20
0.0
1.4
—
—
—
0
0
(3000492) Spirometry study
20
228
0.87
0.20
1.6
1.4
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
11
90
1.23
0.19
2.2
1.6
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
7
59
1.19
0.18
1.3
1.1
—
—
—
0
0
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
14
119
1.19
0.18
1.6
2.5
%
1.4
1.3
0.10
14
119
(3022145) Colonoscopy Study observation
20
226
0.88
0.18
1.3
1.3
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
156
1520
1.06
0.16
3.4
3.8
—
—
—
0
0
(3022621) pH of Urine by Test strip
13
150
0.86
0.15
4.5
2.6
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
92
886
1.06
0.14
2.2
2.5
ug/l
161.4
148.5
0.19
83
818
(3025941) Bacteria identified in Stool by Culture
8
100
0.79
0.14
1.3
1.3
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
100
969
1.05
0.12
3.7
3.8
ng/l
582.3
81.0
0.44
81
700
(3013139) Helicobacter pylori Ag [Presence] in Stool
11
126
0.87
0.11
1.3
1.2
—
—
—
0
0
(3003338) MCHC [Mass/volume]
200
1971
1.05
0.11
29.3
15.9
g/l
333.1
333.8
0.55
200
1959
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
18
198
0.90
0.11
1.8
3.4
ng/l
277.4
203.5
0.19
18
181
(3009542) Hematocrit [Volume Fraction] of Blood
212
2095
1.04
0.09
27.8
12.9
%
39.2
40.7
1.98
174
1446
(3027456) Digoxin [Moles/volume] in Serum or Plasma
5
47
1.06
0.09
3.4
2.6
nmol/l
0.7
0.9
—
5
35
(3020891) Body temperature
11
97
1.14
0.09
3.3
4.5
—
—
—
0
0
(3024731) MCV [Entitic volume]
261
2592
1.07
0.09
35.0
17.9
fl
92.0
91.3
1.55
261
2541
(3035941) MCH [Entitic mass]
261
2592
1.07
0.09
35.0
17.9
pg
30.7
30.5
0.69
261
2541
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
6
56
1.07
0.08
1.8
1.5
—
—
—
0
0
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
5
63
0.79
0.08
1.4
1.0
—
—
—
0
0
(3000963) Hemoglobin [Mass/volume] in Blood
261
2593
1.07
0.08
35.4
18.1
g/l
130.0
139.6
14.89
261
2544
(3043409) Potassium [Moles/volume] in Arterial blood
6
73
0.82
0.07
3.5
4.4
mmol/l
3.9
3.9
—
6
68
(3019309) Folate [Moles/volume] in Red Blood Cells
45
436
1.04
0.05
2.0
1.6
nmol/l
1001.1
1189.8
0.92
33
340
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
14
150
0.93
0.04
1.1
1.3
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
98
995
0.98
0.04
2.1
1.9
pmol/l
93.9
94.7
0.05
55
521
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
76
748
1.02
0.03
2.6
2.6
ug/l
0.8
0.7
0.31
53
481
(4010399)
19
182
1.05
0.02
1.2
1.4
—
—
—
0
0
(3008152) Bicarbonate [Moles/volume] in Arterial blood
15
147
1.02
0.00
8.7
7.5
mmol/l
26.0
24.5
0.74
15
141
(3030862) Granulocytes [#/volume] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
7
77
0.91
0.00
2.1
1.8
—
—
—
0
0
(3032567) Hepatitis B virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
0
8
0.00
0.00
0.0
3.1
—
—
—
0
0
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
0
7
0.00
0.00
0.0
1.7
—
49.1
—
0
7
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
0
5
0.00
0.00
0.0
2.2
—
7.2
—
0
5
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
(3024471) HLA-A [Type]
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3042299) inFLIXimab [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
3.8
—
7.1
—
0
6
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(4198724)
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3024932) HLA-DR beta [Type]
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3016228) CD19 cells/100 cells in Blood
0
6
0.00
0.00
0.0
1.5
—
5.0
—
0
6
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
5
50
1.00
0.00
1.2
1.2
u/l
28.2
13.5
—
5
45
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
0
9
0.00
0.00
0.0
2.0
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013166) Neutrophils/100 leukocytes in Synovial fluid
0
8
0.00
0.00
0.0
1.4
—
55.5
—
0
8
(3042733) HLA Ab [Presence] in Serum
0
7
0.00
0.00
0.0
5.9
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.0
—
1685.0
—
0
9
(3000285) Sodium [Moles/volume] in Blood
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3040370) OLANZapine [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.2
—
103.4
—
0
5
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
6
61
0.98
0.00
1.5
1.6
—
—
—
0
0
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3051101) Glucose [Moles/volume] in Cord blood
0
7
0.00
0.00
0.0
7.7
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.4
—
18.7
—
0
5
(3044009) aPTT.lupus sensitive (LA screen)
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
0
9
0.00
0.00
0.0
2.1
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3019174) dRVVT (LA screen)
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
12.6
—
0.7
—
0
5
(3022689) Creatine [Moles/volume] in Urine
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
0
8
0.00
0.00
0.0
1.3
—
9.3
—
0
8
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: C3_BASEOFTONGUE_EXALLC – Malignant neoplasm of base of tongue, excluding all cancers (controls excluding all cancers)
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).